TradingKey

Mais detalhes de Boston Scientific Corp Empresa

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.

Informações da empresa

Código da empresaBSX

Nome da EmpresaBoston Scientific Corp

Data de listagemMay 19, 1992

CEOMr. Michael F. (Mike) Mahoney

Número de funcionários53000

Tipo de títulosOrdinary Share

Fim do ano fiscalMay 19

Endereço300 Boston Scientific Way

CidadeMARLBOROUGH

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal01752-1234

Telefone15086834000

Sitehttps://www.bostonscientific.com/en-US/Home.html

Código da empresaBSX

Data de listagemMay 19, 1992

CEOMr. Michael F. (Mike) Mahoney

Executivos da empresa

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

2.08K

-58.23%

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

--

Mr. Edward J. Ludwig

Lead Independent Director

--

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Detalhamento da receita

Moeda: USDAtualizado em: dom, 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Electrophysiology

730.00M

15.66%

Interventional Cardiology Therapies

697.00M

14.95%

Endoscopy

673.00M

14.43%

Peripheral Interventions

656.00M

14.07%

Urology

633.00M

13.57%

Other

1.27B

27.32%

Por RegiãoUSD

Nome

Receita

Proporção

United States

2.96B

63.48%

EMEA (Europe, Middle East and Africa)

846.00M

18.14%

Asia Pacific

701.00M

15.03%

Latin America and Canada

155.00M

3.32%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Electrophysiology

730.00M

15.66%

Interventional Cardiology Therapies

697.00M

14.95%

Endoscopy

673.00M

14.43%

Peripheral Interventions

656.00M

14.07%

Urology

633.00M

13.57%

Other

1.27B

27.32%

Distribuição de ações

Atualizado em: há 16 horas

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

9.21%

Fidelity Management & Research Company LLC

7.93%

BlackRock Institutional Trust Company, N.A.

5.28%

State Street Global Advisors (US)

4.35%

PRIMECAP Management Company

2.34%

Other

70.90%

Investidores

Proporção

The Vanguard Group, Inc.

9.21%

Fidelity Management & Research Company LLC

7.93%

BlackRock Institutional Trust Company, N.A.

5.28%

State Street Global Advisors (US)

4.35%

PRIMECAP Management Company

2.34%

Other

70.90%

Tipos de investidores

Investidores

Proporção

Investment Advisor

52.34%

Investment Advisor/Hedge Fund

28.00%

Hedge Fund

3.97%

Pension Fund

2.90%

Research Firm

2.43%

Bank and Trust

1.73%

Sovereign Wealth Fund

1.53%

Family Office

0.22%

Private Equity

0.20%

Other

6.68%

Participação acionária institucional

Atualizado em: ter, 1 de jul

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q2

2752

1.39B

93.57%

+165.36K

2025Q1

2744

1.39B

93.81%

-5.31M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

2023Q1

2012

1.36B

94.85%

-23.81M

Ver Mais

Atividade dos acionistas

Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

133.95M

9.05%

+1.70M

+1.28%

Mar 31, 2025

Fidelity Management & Research Company LLC

117.45M

7.94%

-3.75M

-3.09%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

77.81M

5.26%

+1.08M

+1.41%

Mar 31, 2025

State Street Global Advisors (US)

64.48M

4.36%

+514.79K

+0.80%

Mar 31, 2025

PRIMECAP Management Company

36.50M

2.47%

-432.72K

-1.17%

Mar 31, 2025

Wellington Management Company, LLP

33.20M

2.24%

-2.97M

-8.21%

Mar 31, 2025

Geode Capital Management, L.L.C.

31.80M

2.15%

+1.18M

+3.84%

Mar 31, 2025

Capital World Investors

28.56M

1.93%

+658.82K

+2.36%

Mar 31, 2025

Managed Account Advisors LLC

21.29M

1.44%

+3.60M

+20.36%

Mar 31, 2025

The Bollard Group, LLC

20.49M

1.39%

-242.40K

-1.17%

Mar 31, 2025

Ver Mais

ETFs Relacionados

Atualizado em: qua, 6 de ago

Nome

Proporção

iShares U.S. Medical Devices ETF

11.22%

Goldman Sachs Future Health Care Equity ETF

8.79%

Invesco Dorsey Wright Healthcare Momentum ETF

4.98%

NYLI Healthy Hearts ETF

4.91%

JPMorgan Healthcare Leaders ETF

4.19%

Health Care Select Sector SPDR Fund

3.25%

Proshares Ultra Health Care

3.25%

Global X Aging Population ETF

3.18%

Knowledge Leaders Developed World ETF

3.16%

Bancreek U.S. Large Cap ETF

3.14%

Ver Mais

iShares U.S. Medical Devices ETF

Proporção11.22%

Goldman Sachs Future Health Care Equity ETF

Proporção8.79%

Invesco Dorsey Wright Healthcare Momentum ETF

Proporção4.98%

NYLI Healthy Hearts ETF

Proporção4.91%

JPMorgan Healthcare Leaders ETF

Proporção4.19%

Health Care Select Sector SPDR Fund

Proporção3.25%

Proshares Ultra Health Care

Proporção3.25%

Global X Aging Population ETF

Proporção3.18%

Knowledge Leaders Developed World ETF

Proporção3.16%

Bancreek U.S. Large Cap ETF

Proporção3.14%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

Boston Scientific Corp

102.460USD

Boston Scientific Corp

102.460

Visão Geral

Empresa

Serviços Financeiros